Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01304277
What this trial is testing

This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.

Who this might be right for
Fabry Disease
Shire 17
Testing effectiveness (Phase 2)Looking for participantsNCT07005180
What this trial is testing

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Who this might be right for
Parkinson Disease
Hillhurst Biopharmaceuticals, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00913653
What this trial is testing

Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure

Who this might be right for
Heart Failure
Novartis Pharmaceuticals 30
Very early researchEnded earlyNCT05438667
What this trial is testing

TCR-T Cell Therapy on Advanced Solid Tumors

Who this might be right for
Pancreatic Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Testing effectiveness (Phase 2)Study completedNCT02476019
What this trial is testing

A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients

Who this might be right for
Obesity
Ionis Pharmaceuticals, Inc. 13
Early research (Phase 1)Study completedNCT01741519
What this trial is testing

Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers

Who this might be right for
Healthy
AOP Orphan Pharmaceuticals AG 14
Testing effectiveness (Phase 2)Ended earlyNCT03573544
What this trial is testing

This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.

Who this might be right for
Metastatic Solid TumorsLocally Advanced Solid Tumors
OBI Pharma, Inc 54
Early research (Phase 1)Study completedNCT04488900
What this trial is testing

Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects

Who this might be right for
Healthy Subjects
Chong Kun Dang Pharmaceutical 88
Testing effectiveness (Phase 2)Study completedNCT04311632
What this trial is testing

A Dose Escalation Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
ITB-Med LLC 13
Testing effectiveness (Phase 2)Study completedNCT03334058
What this trial is testing

Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 34
Early research (Phase 1)Looking for participantsNCT06366789
What this trial is testing

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
AML With Gene Mutations
Lomond Therapeutics Holdings, Inc. 150
Early research (Phase 1)Study completedNCT01129258
What this trial is testing

Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders
Pfizer 110
Early research (Phase 1)Study completedNCT06858657
What this trial is testing

A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects

Who this might be right for
Healthy
Haisco Pharmaceutical Group Co., Ltd. 82
Testing effectiveness (Phase 2)Ended earlyNCT01566630
What this trial is testing

Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia

Who this might be right for
Pre-eclampsia
Novartis Pharmaceuticals 3
Early research (Phase 1)Study completedNCT03457649
What this trial is testing

IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
argenx 62
Large-scale testing (Phase 3)Looking for participantsNCT06846385
What this trial is testing

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
Shanghai Mabgeek Biotech.Co.Ltd 160
Early research (Phase 1)Study completedNCT01921647
What this trial is testing

The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

Who this might be right for
Healthy
Yuhan Corporation 95
Testing effectiveness (Phase 2)Looking for participantsNCT07448038
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Who this might be right for
Atherosclerosis
Genentech, Inc. 162
Early research (Phase 1)Study completedNCT02299661
What this trial is testing

Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Renal DiseaseRenal Anemia
Daiichi Sankyo 31
Early research (Phase 1)Study completedNCT05523570
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension

Who this might be right for
Parkinson's Disease
Guangzhou Henovcom Bioscience Co. Ltd. 34
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation